RDPAC Medical Representatives Compliance (MRC) Test

RDPAC is a member and an active player of the global pharmaceutical industry association network, and one of the first industry organizations in China to attach such importance to compliance in the pharmaceutical industry. In order to further enhance the standardization and professionalization of drug promotion activities within the relevant workforce, RDPAC administers the Medical Representatives Compliance (MRC) Test (hereinafter referred to as the "MRC Test") to its member companies. This enhanced MRC Test was officially introduced on January 1, 2024.
RDPAC is set to extend the opportunity for the MRC Test registration to non-RDPAC member companies in June 2024, implementing the same test rules as those for RDPAC member companies (for details regarding test registration and other pertinent matters for non-RDPAC member companies, including score inquiries, please visit: http://mrc.rdpac.org).
The objective of the MRC Test is to deepen candidates’ comprehension of the safe and rational use of drugs, particularly among medical representatives, thus further propelling the standardization and professionalization of their drug promotion activities within the relevant workforce. By studying the necessary fundamentals in preparation for the MRC Test, candidates can reinforce and update their grasp of key knowledge areas encompassed in the industry's self-discipline rules, Chinese laws and regulations. By emphasizing compliance, the MRC Test is expected to unite industry professionals to promote compliance in the pharmaceutical industry while addressing the collective needs of participating companies and underscoring the importance of compliance.

the R&D-based Pharmaceutical Association Committee (RDPAC)

The R&D-Based Pharmaceutical Association Committee (RDPAC), representing 46 leading multinational pharmaceutical companies with R&D capabilities, is a committee under the China Association of Enterprises with Foreign Investment (CAEFI), which in turn reports to the Ministry of Commerce of the People's Republic of China.
Through collaboration with key stakeholders to promote international cooperation and bridge communications between the government and the industry, RDPAC advocates sustainable policies that incentivize pharmaceutical innovation to ensure novel medicines benefit Chinese patients as early and as extensively as possible. It is dedicated to elevating China's pharmaceutical innovation ecosystem to foster higher-quality industry development, and to contributing to ‘Healthy China’ to improve the health and well-being of people in China.

Learn more

Test Rules

1. Test Mode: Closed-book test

2. Test Location: Online

3. Test Duration: [50] mins

4. Question Format: 20 single-choice questions and 5 multiple-choice questions.

5. Knowledge Areas Covered: The test will encompass three key areas, including RDPAC Code of Practice (2022 Revision), Chinese laws and regulations, and general principles of medical ethics.

6. Question Distribution: The test consists of a total of 25 questions, with 19 focusing on the RDPAC Code of Practice (2022 Revision), 5 on Chinese laws and regulations, and 1 on general principles of medical ethics.

7. Test Schedule: The MRC Test is held monthly and each candidate may register for the test for up to two months per year. Upon successful registration, candidates will have three opportunities to take the test within the registered month.

8. Passing Criteria: Candidates must answer 20 or more questions correctly in any test attempt to pass the test.

9. Test Precautions

10. Test Discipline

2024 MRC Test Calendar

Registration dates Online test dates

Registration Procedure

The designated MRC contact person from each company will enroll the company's candidates for the test

Score Inquires

2019-2023 MRC Exam Score Inquiry Platform: https://c.exam-sp.com/index.html#/e/mrc-result/login

MRC test Data Management Notice

We comply with the "Personal Information Protection Law" and other relevant laws and regulations to manage and protect data. To better manage and protect the personal information and test data of MRC candidates, and considering the time relevance of test results, RDPAC has set the retention period for MRC test data to 5-6 years. Relevant entities and candidates can access the data. For example, in 2024, one can access test results from 2019 to 2024, and in 2025, one can retrieve results from 2020 to 2025. Data exceeding the retention period will be deleted.

Consultation on test-related questions:MRC-test@ata.net.cn

Feedback:MRC@rdpac.org

For details regarding test registration and other pertinent matters for non-RDPAC member companies, including score inquiries, please visit: http://mrc.rdpac.org